Regulatory approval proves medical benefit? We disagree. Reimbursed technologies that have been exploited or result in unnecessary care are too numerous to list. We take this one step further and analyze eight questions to help determine medical appropriateness and long-term clinical consequences. The advantage is not only humanitarian. It reduces risk of poor global acceptance or a future disruptive reimbursement decrease.